Publication Year

Gupta N, Patel HD, Taylor J, Borin JF, Jacobsohn K,…, Price C, et al. 2022. Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. Prostate Cancer Prostatic Dis 25(3):444–452; doi: 10.1038/s41391-022-00553-2.

Habib A, Sacks NC, Cool C, Durgapal S, Hughes T, Hernandez J, Phillips G. Trends in hospital admissions and readmissions for patients with MG from U.S. national research databases. Poster presentation, American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting, September 2022.

Sacks NC. Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research (ISPOR)Europe, November 2022.

Tsvetkov L, Pittsenbarger J, Atsriku C, Devine P, Dingley K, et al. 2022. Inhibition of CDC7 with Sgr-2921 in AML models results in enhanced DNA damage and anti-leukemic activity as monotherapy and in combination with standard of care agents. Blood 140 (Supplement 1):5961–5962; doi: 10.1182/blood-2022-167239.

Bonkowsky J, Healey B, Sacks NC, Mclin R, Cyr PL, Sawyer E, Stephen CB, et al. Burden of illness and mortality in adult men with adrenomyeloneuropathy: A retrospective study of real-world data. American Academy of Neurology, Seattle, WA, 2022

Jensen IS, Wu E, Cyr PL, Claussen M, Winkler T, Salahuddin K, Prats J, et al. 2022. Cost-consequence analysis of using cangrelor in high angiographic risk percutaneous coronary intervention patients: A US hospital perspective. Am J Cardiovasc Drugs 22(1):93-104; doi: 10.1007/s40256-021-00491-9. PMID: 34331235.

Alexander AW, Jensen IJ, Hathaway J, Srivastava K, Cyr PL, Sidonio RF, Batt K. 2022. Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements. J Manag Care Spec Pharm 28(5):518-527; doi: 10.18553/jmcp.2022.21197. PMID: 35343812.

Price C. 2022. Syntheses synthesized: A look back at Grant and Booth’s review typology. Evid-based Libr Info Prac 17(2):132–138; doi: 10.18438/eblip30093.

Damania R, Price C, Grunwell J, Kamat P. Future of pediatric critical care remote learning: Role and reach of a podcast series. Virtual presentation to Society of Critical Care Medicine 51st Critical Care Congress, 2022.

Rivera BN, Wilson LB, Kim DM, Pande P, Anderson KA, Tilton SC, Tanguay RL. 2022. A comparative multi-system approach to characterizing bioactivity of commonly occurring chemicals. Int J Environ Res Public Health 19(7):3829; doi: 10.3390/ijerph19073829. PMID: 35409514.

Price C. Bit by byte: Building best practices in data literacy [poster]. Medical Library Association (MLA) Annual Meeting and Exhibition, New Orleans, LA, 2022.

Price C, Lebo R, Seal S, Whalen M. 2022. Searching for evidence. In: Dang D, Dearholt SL, Bissett K, Ascenzi J, Whalen M. Johns Hopkins Evidence-Based Practice for Nurses and Healthcare Professionals: Model and Guidelines, 4th ed. Sigma Theta Tau International; http://www.worldcat.org/oclc/1261367148.

Barker T, Stone J, Hasanoff S, Stevenson J, Price C, Kabaghe A, Munn Z. 2022. Dual-active-ingredient, insecticidal nets for preventing malaria: A systematic review protocol [version 1; peer review: 1 not approved]. F1000Research, 11:1020; https://doi.org/10.12688/f1000research.123983.1.

Munn Z, Pollock D, Price C, Aromataris E, Stern C, Stone J, et al. 2022. Investigating different typologies for the synthesis of evidence: A scoping review protocol. JBI Evidence Synthesis; https://doi.org/10.11124/JBIES-22-00122.

Cleveland B, Norling B, Wang H, Gandhi V, Price CL, Borofsky M, et al. 2022. Tranexamic acid for percutaneous nephrolithotomy. Cochrane Database of Systematic Reviews (3); https://doi.org/10.1002/14651858.CD015122.

Lea IA, Pham LL, Antonijevic T, Thompson C, Borghoff SJ. 2022. Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances. Regul Toxicol Pharmacol 133(August):105190; doi: 10.1016/j.yrtph.2022.105190. PMID: 35662637.

Sacks NC, Healey BE, Raza S, Cyr PL, Boerner G, Sheshadri A. 2022. The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States. Blood Adv 6(5):1566–1576; doi: 10.1182/bloodadvances.2021004364. PMID: 34807973.

Sheshadri A, Sacks NC, Healey B, Cyr P, Boerner G, Huang HJ. 2022. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States. J Med Econ 25(1):650–659; doi: 10.1080/13696998.2022.2071065. PMID: 35502563.

Sheshadri A, Sacks NC, Healey BE, Raza S, Boerner G, Huang HJ. 2022. Lung function monitoring after lung transplantation and allogeneic hematopoietic stem cell transplantation. Clin Ther 44(5):755–765; doi: 10.1016/j.clinthera.2022.03.011. PMID: 35513911.

Henderson RG, Nguyen H. 2022. Pathways to the US supplement market: New dietary ingredient notification and Generally Recognized as Safe determination. Chapter 19 in: Ruthsatz M, Wong AW (eds), Nutrition, Health, and Disease: Regulatory Policy Matters. Regulatory Affairs Professionals Society, E-Book, 427 pp., ISBN: 978-1-947493-82-7.